175 related articles for article (PubMed ID: 7883517)
1. [Are proton pump inhibitors safe?].
Creutzfeldt W
Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
[No Abstract] [Full Text] [Related]
2. [Drug interactions. Proton pump inhibitors II].
Zaigler M
Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
[No Abstract] [Full Text] [Related]
3. [Proton pump inhibitors: Pantoprazole].
Takeuchi K; Hase S
Nihon Rinsho; 2002 Feb; 60 Suppl 2():655-60. PubMed ID: 11979865
[No Abstract] [Full Text] [Related]
4. Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.
Becker TL; Maróstica M; Ribeiro ML; de Mendonça S; Gambero A; Pedrazzoli J
Int Immunopharmacol; 2004 Aug; 4(8):1051-7. PubMed ID: 15222979
[TBL] [Abstract][Full Text] [Related]
5. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
[TBL] [Abstract][Full Text] [Related]
6. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
Leonhardt U; Ritzel U; Ramadori G
Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
[No Abstract] [Full Text] [Related]
7. [Do other proton pump blockers have advantages over Antra (omeprazole)?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689
[No Abstract] [Full Text] [Related]
8. Protonix. First i.v. proton pump inhibitor approved.
Nursing; 2002 Feb; 32(2):18, 20. PubMed ID: 11924161
[No Abstract] [Full Text] [Related]
9. Apparent anaphylaxis associated with pantoprazole.
Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
[No Abstract] [Full Text] [Related]
10. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
Wang L; Zhou L; Lin S; Hu H; Xia J
J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
[TBL] [Abstract][Full Text] [Related]
11. [Drug interactions. Proton pump inhibitors. 1].
Gleiter CH
Internist (Berl); 1998 Aug; 39(8):874-5. PubMed ID: 9757395
[No Abstract] [Full Text] [Related]
12. Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.
Bardhan KD; Cherian P; Bishop AE; Polak JM; Romanska H; Perry MJ; Rowland A; Thompson M; Morris P; Schneider A; Fischer R; Ng W; Lühmann R; McCaldin B
Am J Gastroenterol; 2001 Jun; 96(6):1767-76. PubMed ID: 11419827
[TBL] [Abstract][Full Text] [Related]
13. [Choice of proton pump inhibitors--does it play any role?].
Hellström PM
Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2620-1. PubMed ID: 15534636
[No Abstract] [Full Text] [Related]
14. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
Sennaroglu E; Karakan S; Kayatas M; Akdur S; Genc H; Karakan T; Ucler R; Ozisler C; Urun Y
Dig Dis Sci; 2006 Jan; 51(1):121-2. PubMed ID: 16416223
[No Abstract] [Full Text] [Related]
15. [Dosaging of proton pumps inhibitors].
Brørs O
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2397-9. PubMed ID: 16998554
[No Abstract] [Full Text] [Related]
16. Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
Bliesath H; Simon B; Hartmann M; Müller P; Schneider A; Lühmann R; Wurst W
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):439. PubMed ID: 1337063
[No Abstract] [Full Text] [Related]
17. Pantoprazole-induced recurrent anaphylactic shock.
Fardet L; Izzedine H; Ciroldi M; Tiev KP; Cabane J
Am J Gastroenterol; 2002 Nov; 97(11):2933. PubMed ID: 12425583
[No Abstract] [Full Text] [Related]
18. ["Mirror, mirror on the wall which is the best proton pump inhibitor of all?"].
Labenz J; Petersen KU; Rösch W; Koelz HR
Z Gastroenterol; 2003 Nov; 41(11):1123. PubMed ID: 14648385
[No Abstract] [Full Text] [Related]
19. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
20. Proton-pump inhibitors: three of a kind?
Bateman DN
Lancet; 1997 Jun; 349(9066):1637-8. PubMed ID: 9186377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
